Preoperative evaluation of kidney function, hemodynamic status, and urinary biomarkers such as VDBP and KIM-1 may provide a comprehensive risk stratification strategy for anticipating postoperative AKI in advanced heart failure patients undergoing LVAD implantation. This evidence concerns the gene HAVCR1 and heart failure.